IP Library Granted Patent US 7,381,825
Granted Patent B2
US 7,381,825 · App. 10/803,575 · Granted Jun 3, 2008

Histone deacetylase inhibitors

Assignee: Takeda San Diego, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,381,825
App. No.
10/803,575
Granted
Jun 3, 2008
Kind
B2
Abstract

Compounds that may be used to inhibit histone deacetylase having the formula Z-Q-L-M or Z-L-M wherein M is a substituent capable of complexing with a deacetylase catalytic site and/or a metal ion; L is a substituent providing between 0-10 atoms separation between the M substituent and the remainder of the compound; and Z and Q are as defined herein.

Claims (49)

1. A compound consisting of the formula:

Z-Q-L-M

wherein

Z-Q- is selected from the group consisting of

V is selected from the group consisting of C(R 12 ) 2 and NR 12 where only one V is NR 12 ;

R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of hydrogen, halo, alkyl, alkoxy, aryl, heteroaryl, aminosulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aryloxy, heteroaryloxy, arylalkyl, heteroarylalkyl, amino, thio, cyano, nitro, and a carbonyl group, each substituted or unsubstituted;

each R 12 is independently selected from the group consisting of hydrogen, halo, alkyl, alkoxy, aryl, heteroaryl, aminosulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aryloxy, heteroaryloxy, arylalkyl, heteroarylalkyl, amino, thio, cyano, nitro, and a carbonyl group, each substituted or unsubstituted, with the proviso that when the ring atom to which R 12 is bound is nitrogen, R 12 not halo, cyano, nitro, or thio;

M is selected from the group consisting of trifluoroacetyl (—C(O)—CF 3 ), —NH—P(O)OH—CH 3 , sulfonamides (—SO 2 NH 2 ), hydroxysulfonamides (—SO 2 NHOH), thiols (—SH), and carbonyl groups having the formula —C(O)—R 13 wherein R 13 is hydroxylamino, hydroxyl, amino, alkylamino, and an alkoxy group; and

L is a substituent providing between 2-10 atoms separation between the M substituent and the Q substituent, wherein the 2-10 atoms are all carbon atoms.

2. The compound according to claim 1 , wherein V are selected so that the ring is an N-substituted piperidin-3-yl moiety.

3. The compound according to claim 1 , wherein at least one of R 2 , R 3 , R 4 , or R 5 is fluoro.

4. The compound according to claim 1 , wherein M is selected from the group consisting of:

5. The compound according to claim 1 , wherein M is a hydroxamic acid moiety.

6. A compound according to claim 1 , wherein -L-M is

7. A compound comprising the formula:

Z-Q-L-M

wherein

Z-Q- is selected from the group consisting of

each V is selected from the group consisting of C(R 12 ) 2 and NR 12 where only one V is NR 12 ;

R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of hydrogen, halo, alkyl, alkoxy, aryl, cyano, and nitro;

each R 12 is independently selected from the group consisting of hydrogen, halo, alkyl, alkoxy, aryl, heteroaryl, aminosulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aryloxy, heteroaryloxy, arylalkyl, heteroarylalkyl, amino, thio, cyano, nitro, and a carbonyl group, each substituted or unsubstituted, with the proviso that when the ring atom to which R 12 is bound is nitrogen, R 12 is not halo, cyano, nitro, or thio;

M is selected from the group consisting of trifluoroacetyl (—C(O)—CF 3 ), —NH—P(O)OH—CH 3 , sulfonamides (—SO 2 NH 2 ), hydroxysulfonamides (—SO 2 NHOH), thiols (—SH), and carbonyl groups having the formula —C(O)—R 13 wherein R 13 is hydroxylamino, hydroxyl, amino, alkylamino, and an alkoxy group; and

L is selected from the group consisting of (E) isomer of —CH═CH—, (Z) isomer of —CHCH—, and mixtures of(E) and (Z) isomers of —CH═CH—.

8. The compound according to claim 7 , wherein V are selected so that the ring is an N-substituted piperidin-3-yl moiety.

9. The compound according to claim 7 wherein at least one of R 2 , R 3 , R 4 , or R 5 is fluoro.

10. The compound according to claim 7 , wherein M is selected from the group consisting of:

11. The compound according to claim 7 , wherein M is a hydroxamic acid moiety.

12. The compound according to claim 7 , wherein -L-M is

13. The compound according to claim 1 , wherein M is

14. The compound according to claim 1 , wherein M is

15. The compound according to claim 1 , wherein M is

16. The compound according to claim 1 , wherein M is

17. The comnound according to claim 1 , wherein M is

18. The compound according to claim 1 , wherein M is

19. The compound according to claim 1 , wherein M is

20. The compound according to claim 1 , wherein M is

21. The compound according to claim 1 , wherein M is

22. The compound according to claim 1 , wherein M is

23. The compound according to claim 7 , wherein M is

24. The compound according to claim 7 , wherein M is

25. The compound according to claim 7 , wherein M is

26. The compound according to claim 7 , wherein M is

27. The compound according to claim 7 , wherein M is

28. The compound according to claim 7 , wherein M is

29. The compound according to claim 7 , wherein M is

30. The compound according to claim 7 , wherein M is

31. The compound according to claim 7 , wherein M is

32. The compound according to claim 7 , wherein M is

33. The compound according to claim 1 , wherein -L-M is

Assignments (2)
CHANGE OF NAME Recorded Aug 16, 2006
From: SYRX, INC.
To: TAKEDA SAN DIEGO, INC.
Reel/Frame 018132/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2004
From: BRESSI, JEROME C.; BROWN, JASON W.; CAO, SHELDON X.; GANGLOFF, ANTHONY R.; JENNINGS, ANDREW J.; STAFFORD, JEFFREY A.; VU, PHONG H.; XIAO, XIAO-YI
To: SYRRX, INC.
Reel/Frame 015455/0871 →
Continuity (3)
Provisional Application 6045543700 · Mar 17, 2003
Provisional Application 6053120300 · Dec 19, 2003
Related Publication 20040254220A1 · Dec 16, 2004